Skip to Content
 

E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us

    News: Faculty Staff News

    2016 Star Award recipients announced

    Tuesday, May 2nd, 2017

    The Vanderbilt-Ingram Cancer Center (VICC) Star Awards are awarded by VICC leadership annually to Cancer Center members to recognize their efforts and leadership among our researchers and clinicians in the following categories: Publications in High Impact Journals Accruals to Therapeutic Clinical Trials Accruals to Non-Therapeutic Clinical Trials For full list, see CY2016 Star Award Announcement  

    VUMC to Study Potential Approach to Reverse Precancerous Stomach Lesions

    Thursday, April 27th, 2017

    Vanderbilt University Medical Center (VUMC) cancer researcher James Goldenring, M.D., Ph.D., has received a two-year, $200,000 grant from the DeGregorio Family Foundation in Pleasantville, New York, to begin clinical trials of a potential approach for reversing precancerous stomach lesions. Stomach cancer is the fourth leading cause of cancer-related deaths worldwide after lung, liver and colorectal […]

    Vanderbilt’s Christine Lovly Elected to American Society for Clinical Investigation

    Thursday, April 27th, 2017

    Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected to The American Society for Clinical Investigation (ASCI). The ASCI is an elite honor society of physician-scientists. The Society, founded in 1908, is home to nearly 3,000 members from the upper ranks of academic medicine […]

    Vanderbilt’s W. Kimryn Rathmell named to ASCI leadership post

    Thursday, April 20th, 2017

    W. Kimryn Rathmell, M.D., Ph.D., director of the Division of Hematology/Oncology at Vanderbilt University Medical Center (VUMC), has been named vice president of The American Society for Clinical Investigation (ASCI). W. Kimryn Rathmell, M.D., Ph.D. Rathmell, who is the Cornelius Abernathy Craig Professor of Medicine, will serve a four-year term, initially as vice president, then […]

    Vanderbilt’s Pietenpol joins Sledge as a Chief Scientific Advisor for Susan G. Komen

    Thursday, April 6th, 2017

    Jennifer Pietenpol, Ph.D., Executive Vice President for Research at Vanderbilt University Medical Center (VUMC) and director of Vanderbilt-Ingram Cancer Center (VICC), has been named a Chief Scientific Advisor (CSA) for the nonprofit breast cancer organization Susan G. Komen. Jennifer Pietenpol, Ph.D. She joins George Sledge Jr., M.D., professor of Medicine at Stanford University Medical Center, […]

    Vanderbilt Researcher Awarded Stand Up To Cancer Research Grant for “Smart” Nanoparticles Cancer Research

    Tuesday, April 4th, 2017

    John T. Wilson, Ph.D., assistant professor of Chemical and Biomolecular Engineering and of Biomedical Engineering at Vanderbilt University, has received an Innovative Research Grant from Stand Up To Cancer (SU2C). Wilson is among 10 early-career scientists to receive the grant awards focused on immuno-oncology. SU2C announced the award of $7.5 million in Innovative Research Grants […]

    Penson to chair urology association’s science, quality council

    Sunday, April 2nd, 2017

    David Penson, M.D., MPH, Paul V. Hamilton, M.D., and Virginia E. Howd Professor of Urologic Oncology and chair of the Department of Urologic Surgery, has been selected to chair the American Urological Association (AUA) Science & Quality Council, according to an announcement from the AUA Board of Directors. Penson will assume the role of chair-elect […]

    Breast cancer program lands new research grants

    Friday, March 24th, 2017

    Several investigators in Vanderbilt-Ingram Cancer Center’s (VICC) Breast Cancer Program have received grant awards to support translational research that may improve disease outcomes for patients. The grants totaling more than $3 million will fund mechanistic science and clinical trials designed to test novel therapy combinations and determine why some forms of breast cancer become resistant […]

    Morton to help lead blood disorders treatment efforts

    Thursday, January 12th, 2017

    Colleen Morton, M.D., has joined Vanderbilt University Medical Center (VUMC) as section chief of Classical Hematology, a specialty also known as “benign hematology” because it covers all blood disorders that are not cancer. Colleen Morton, M.D. In the newly created position, Morton oversees VUMC’s treatment of patients with bleeding disorders like von Willebrand disease, blood […]

    Moses elected to National Academy of Inventors

    Wednesday, January 4th, 2017

    Harold (Hal) Moses, M.D., Ingram Professor of Cancer Research and director emeritus of Vanderbilt-Ingram Cancer Center (VICC), has been named a Fellow of the National Academy of Inventors (NAI). Moses, professor and interim chair of Cancer Biology, is among 175 academic leaders named to the 2016 class of NAI Fellows. Harold L. (Hal) Moses, M.D. […]

    Next Page »« Previous Page

    E-Newsletter

  • Subscribe to our e-Newsletter to receive email updates:

  • Related Articles

    Most Recent

    Archives

    Join Us